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Saliva of blood-feeding arthropods carries several antihemo-
static compounds whose physiological role is to facilitate suc-
cessful acquisition of blood. The identification of novel natural
anticoagulants and the understanding of their mechanism of
actionmay offer opportunities for designing new antithrombot-
ics disrupting blood clotting.We report here an in-depth struc-
tural and functional analysis of the anophelin family member
cE5, a salivary protein from the major African malaria vector
Anopheles gambiae that specifically, tightly, and quickly binds
and inhibits thrombin.Using calorimetry, functional assays, and
complementary structural techniques, we show that the central
region of the protein, encompassing amino acids Asp-31–Arg-
62, is the regionmainly responsible for-thrombin binding and
inhibition. As previously reported for the Anopheles albimanus
orthologue anophelin, cE5 binds both thrombin exosite I with
segment Glu-35–Asp-47 and the catalytic site with the region
Pro-49–Arg-56,which includes the highly conservedDPGR tet-
rapeptide. Moreover, the N-terminal Ala-1–Ser-30 region of
cE5 (which includes an RGD tripeptide) and the additional
C-terminal serine-rich Asn-63–Glu-82 region (absent in ortho-
logues from anophelines of the New World species A. albima-
nus and Anopheles darlingi) also played some functionally rele-
vant role. Indeed, we observed decreased thrombin binding and
inhibitory properties even when using the central cE5 fragment
(Asp-31–Arg-62) alone. In summary, these results shed addi-
tional light on the mechanism of thrombin binding and inhibi-
tion by this family of salivary anticoagulants from anopheline
mosquitoes.
The ability of hematophagous insects to use blood as a food
source involves complex behavioral, morphological, and phys-
iological adaptations to find suitable hosts, pierce their skin,
and efficiently acquire and digest blood. As a result, the saliva of
blood-feeding arthropods carries a complex mixture of com-
pounds playing crucial roles in counteracting the three power-
ful and highly redundant responses of vertebrates to tissue inju-
ry: hemostasis, inflammation, and immunity (1). Blood feeding
evolved independently several times in different taxa (2), and
this resulted in a large variety of salivary anti-hemostatic factors
targeting platelet aggregation, vasoconstriction, and blood clot-
ting (1, 3). Salivary anticoagulants found in themosquito family
offer a good example of this convergent evolution; members of
the Culicinae subfamily (i.e. Aedes and Culex species) inhibit
factor Xa, whereas species belonging to the anopheline subfam-
ily adopted a thrombin-directed anticoagulant activity (4).
The anti-thrombin of anopheline mosquitoes was first iden-
tified in the South American malaria vector Anopheles albima-
nus as a small cysteine-less polypeptide of 61 amino acids
named anophelin (5). Synthetic anophelin was shown to be a
highly specific, slow, tight-binding, reversible inhibitor of
-thrombin (6). It binds both the catalytic site and the anion
binding exosite 1 (TABE1) of thrombin, a region that is known
to be involved in the recognition of fibrinogen (7). A cDNA
encoding the anophelin orthologue in the African malaria vec-
tor Anopheles gambiae had been previously identified by a
selective cloning strategy and the encoded protein named cE5
(8). The two proteins, anophelin and cE5, are quite divergent
(43% identity) with the slightly longer A. gambiae protein (82
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amino acids) displaying an additional stretch of amino acids at
theC terminus.Despite these differences, recombinantA. gam-
biae cE5 showed full preservation of anti-thrombin function,
although the two proteins displayed slightly different binding
kinetics. The A. albimanus anophelin is a slow-binding throm-
bin inhibitor (6), whereas the A. gambiae cE5 behaves as a fast-
binding inhibitor (9), raising the possibility that the extended
C-terminal may participate in thrombin binding.
The crystal structure of the A. albimanus anophelin in com-
plex with human thrombin revealed its unique inhibition
mechanism in comparison to other known thrombin inhibitors
(10). In particular, theC-terminal segment (A(Glu-32–Pro-61))
appeared sufficient for thrombin inhibition, with residues
A(Asp-33–Phe-45) blocking the exosite I and the highly con-
served DPGR tetrapeptide (A(Asp-50–Arg-53)) occupying the
active site cleft of the enzyme and disrupting the characteristic
catalytic triad of the serine proteinase.
The release of the genomes of 16 Anophelesmosquitoes (11)
allowed identifying anophelin/cE5 orthologues from several
additional species, offering further insights into the evolution of
this unique family of thrombin inhibitors. Multiple alignment
of cE5/anophelin family members showed that, in comparison
to the New World species A. albimanus and Anopheles dar-
lingi, orthologues from the Old World Anopheles species dis-
play an extended, serine-rich, C-terminal region (10, 12). In
order to investigate the possible involvement of the C-terminal
region (cE5(Asn-63–Glu-82)) in thrombin-binding and inhibi-
tion as well as the role of the conserved N-terminal portion
(cE5(Ala-1–Ser-30)), we performed a structural and functional
analysis using both the cE5 protein and a set of cE5-derived
peptides. Moreover, the three-dimensional structure of the
human -thrombin–A. gambiae cE5 complex unveiled the
details of thrombin recognition and inhibition by an anophelin
orthologue from an Old World Anopheles species.
Results
Structural properties of cE5 as determined by circular
dichroism and NMR spectroscopy
Prediction analysis carried out by DISOPRED (VL-XT pre-
dictor; www.pondr.com)3 (50) suggested that the cE5 protein,
as previously reported for theA. albimanus anophelin (10), was
intrinsically disordered in solution. However, in contrast to
A. albimanus anophelin, cE5 displayed a slight propensity to be
structured in the region encompassing amino acids cE5(Pro-
54) to cE5(Ser-64) (Fig. 1). Similar results were obtained using
the database of intrinsically disordered proteins, MobiDB (not
shown) (13). Furthermore, cE5 displayed a typical circular
dichroism (CD) spectrum of an unstructured protein, with a
minimum at 202 nm (Fig. 2). After the addition of 2,2,2-trifluo-
roethanol (TFE)4 as co-solvent, which may help exploring the
intrinsic tendency of a polypeptide to assume secondary struc-
ture elements (14–16), we found a very lowpropensity of cE5 to
adopt an -helical conformation. Indeed, even with high con-
centrations of TFE (60%), an increase of only 10% in the
-helical content was observed (inset in Fig. 2).
The conformational properties of cE5 were also investigated
using NMR spectroscopy. The 1H,15NHSQC spectrum of 15N-
labeled cE5 showed a limited chemical shift range (Fig. 3A),
indicative of an unfoldedmolecule having few secondary struc-
ture elements, consistent with the random-coil state suggested
by CD data. In addition, the 1H,15NHSQC spectra of uniformly
15N-labeled cE5 (40 M) in the absence and the presence of
different amounts of TFE (10, 30, and 60% (v/v)) (Fig. 3, B–D)
were recorded in the same experimental conditions used for
CD analyses. In complete agreement with the CD data, these
NMR experiments indicated a continuous increase in signal
dispersion (i.e. in structuration) with increasing TFE concen-
tration. However, even at relatively high TFE concentrations,
HSQC spectra still resemble those of canonical intrinsically dis-
ordered proteins (Fig. 3, B–D).
Alignment of anophelin familymembers from different
Anopheles species
The sequencing of the genomes of 16 anopheline species (11)
spanning 100 million years of evolution allowed identifica-
tion of several additional members of the cE5/anophelin family
(12). Alignment of the 18 full-length orthologues highlighted
their considerable divergence: 18–77% amino acid identity
among the differentAnopheles species (excluding comparisons
within the A. gambiae species complex). Overall, a block of 16
amino acids, including the highly conserved tetrapeptide
APQY, can be recognized at theN-terminal region, and another
highly conserved tetrapeptide, DPGR, is found toward the C
terminus (Fig. 4). Between these two conserved blocks there is a
more divergent central region enriched in acidic residues (Asp
Glu 19–33%). A careful examination of the aligned proteins
disclosed three features of potential functional relevance: (i) the
N-terminal RGD tripeptide in A. gambiae and in a few other
species of the complex; (ii) the conserved DPGR tetrapeptide,
with proline to alanine replacement in Anopheles atroparvus
andAnopheles epiroticus; (iii) the presence of a longer C-termi-
nal in Old World anophelines.
3 Please note that the JBC is not responsible for the long-term archiving and
maintenance of this site or any other third party hosted site.
4 The abbreviations used are: TFE, 2,2,2-trifluoroethanol; HSQC, heteronuclear
single quantum correlation; ITC, isothermal titration calorimetry; PCTP,
sodium propionate, sodium cacodylate trihydrate, bis-Tris propane; bis-Tris,
2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol.
Figure 1. Disorder prediction of theA. gambiae cE5 protein. Prediction of
naturally disordered regions in the primary sequence of cE5 (VL-XT predictor)
(44). Residues exceeding a threshold value of 0.5 are considered disordered.
A. gambiae cE5–thrombin interaction
J. Biol. Chem. (2017) 292(30) 12632–12642 12633
 at U
N
IV
ERSITÀ STUDI LA SAPIENZA on March 28, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Figure 3. NMR spectroscopy of the A. gambiae cE5 protein. A, 1H,15N HSQC spectrum of uniformly 15N-labeled cE5 (20M in 50mM sodium phosphate, pH
7.8; sample total volume: 550 l with 10% D2O). B–D, monitoring the effect of TFE on the intrinsically disordered protein cE5. Comparison of HSQC spectra of
15N-labeled cE5 in the absence (red) and in the presence of TFE at increasing concentrations: B, 10% (green); C, 30% (cyan);D, 60% (blue).NaP stands for sodium
phosphate buffer.
Figure2. FarUVCDspectraof the cE5protein.CDspectraof cE5 (10M in10mMphosphatebuffer pH7.5) alone (solid line) andafter the additionof 60% (v/v)
TFE (dotted line). The inset shows the molar ellipticity at 220 nm in the presence of increasing concentrations of TFE.
A. gambiae cE5–thrombin interaction
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The tripeptide RGD is known for its involvement in binding
to integrins (17). RGD-containing proteins with anti-platelet
activity (disintegrins) have been found in snake venoms and in
the saliva of blood-feeding arthropods (ticks and horseflies),
leeches, andworms but never inmosquitoes. Disintegrins act as
antagonists of integrinIIb3 and inhibit fibrinogen binding to
platelets and subsequent platelet cross-linking (18). Typically,
integrin-binding RGDmotifs are positioned in the loop of pep-
tide hairpins formed by disulfide bonds (19), which is not the
case for the cE5 RGD. We tested cE5 and the cE5-derived P1
peptide (Fig. 4) in platelet aggregation assays. We found no or
very little effect on platelet aggregation (supplemental Fig. S1),
which seems to rule out interaction of cE5 RGD with integrin
IIb3 (even though we cannot exclude binding to other
integrins).
The DPGR tetrapeptide was previously found to play a cru-
cial role in in vitro binding to -thrombin (20) and shown to
occupy the active-site cleft of the enzyme in the anophelin/
thrombin crystal structure (10). Substitutions of the catalytic
triad-disrupting aspartate and of the S1-targeting arginine res-
idues in the A. albimanus protein were detrimental for the
inhibitory activity (10). We do not know the effect of replacing
the proline in this tetrapeptide with an alanine. However, it is
conceivable that given the compact size of alanine, it may
replace the pivotal proline residue without much impact in
inhibitor activity.
Intriguingly, Old World anophelines (subgenera Cellia and
Anopheles) carry an additional serine-enriched (29–56%)
C-terminal stretch of 7–21 amino acids that is absent in the
New World species A. albimanus and A. darlingi (subgenus
Nyssorhynchus). It has been previously shown that the
anophelin C-terminal fragment A(Glu-32–Pro-61) is mainly
responsible for both binding to and inhibiting thrombin. Frag-
ment A(Ala-1–Asp-31) did not appear to play any functional
role in thrombin targeting and inhibition (10). However,
A. gambiae cE5 appeared to possess higher affinity for throm-
bin and more potent anticoagulant activity than A. albimanus
anophelin (Ki 3.5 pM versus 34 pM; prolongation of thrombin
time from 16 to 221 s for cE5 and to 84 s for anophelin) (9, 10).
Moreover, anophelin and cE5 also displayed different kinetics
of binding to thrombin, the former being a slow-binding
thrombin inhibitor (6) and the latter behaving as a fast-binding
inhibitor (9). To evaluate the possible role of the C-terminal
serine-rich fragment of cE5, we designed the peptides P1
(cE5(Ala-1–Ser-30)), P2 (cE5(Asp-31–Arg-62)), P3 (cE5(Asn-
63–Glu-82)), and P5 (cE5(Asp-31–Glu-82)) (Fig. 4) and
assessed their interactionwith thrombin by isothermal titration
calorimetry (ITC) and enzymatic assays.
Binding studies
As determined by ITC, cE5 formed a very stable complex
with thrombin (Kd  1 nM), with an apparent affinity slightly
higher than anophelin (Kd 2 nM; Table 1, Fig. 5, A and B). In
addition, binding assays with the cE5-based peptides P1, P2, P3,
and P5 suggested that the region involved in the interaction
with thrombin resides almost completely on the fragment
cE5(Asp-31–Arg-62), corresponding to the P2 peptide (Kd12
nM). This was underscored by the comparable H values
obtained for cE5 (9.85 kcal/mol) and P2 (9.66 kcal/mol)
(Table 1 and Fig. 5, C–E). Surprisingly, binding experiments
with a P5 yielded larger Kd (25 nM) and smaller H (4.89
kcal/mol) values than those obtained for P2, pointing to a
negative contribution in thrombin-binding of the region
corresponding to P3 in the absence of the N-terminal por-
tion encompassed by P1 (Table 1, Fig. 5F).
It is worth noting that the binding affinity (Ka) of cE5 to
thrombin is beyond the limit of direct calorimetric determina-
tion. Under these conditions, ITC titration still provides an
accurate measurement of the binding enthalpy (Table 1). How-
ever, ITC can be used to determine the complete binding ther-
modynamics of ligands with affinities down to the picomolar
range using displacement titration (21), which was performed
for this system in the presence of a weak thrombin inhibitor,
the synthetic tetrapeptide D-Phe–Pro–D-Arg–Ala (22). Under
these conditions, cE5 displayed a binding constant of 0.3 nM
(Table 1, supplemental Fig. S2, and supplemental Equation 1),
Figure 4.Multiple alignment of cE5/anophelin familymembers from18Anopheles species. The conservedN-terminal region and theDPGR tetrapeptide
(highlighted in red) are boxed. Serine residues in the C-terminal region are shown inwhite lettering on a black background. Residues conserved in all or at least
in 75% of the aligned sequences are highlighted in yellow and green, respectively. The peptides used in this study are represented above the aligned proteins.
Regions of the cE5 protein shownby crystallographic analysis to interactwith the exosite I and the catalytic site of thrombin are indicated below the alignment,
as are their flanking residues. VectorBase accession numbers: A. gambiae, AGAP008004; Anopheles coluzzii, ACOM030673; Anopheles arabiensis, AARA005120;
Anopheles quadriannulatus, AQUA000660; Anopheles merus, AMEM012461; Anopheles funestus, AFUN004964; Anopheles minimus, AMIN006263; Anopheles
culicifacies, ACUA026308; Anopheles stephensi, ASTE006313; Anopheles dirus, ADIR011024; Anopheles sinensis, ASIS010361; A. albimanus, AALB014019. Gen-
BankTM accession number: A. darlingi, GI:208657572. Sequences of the Anopheles melas, Anopheles christyi, A. epiroticus, Anopheles farauti, and A. atroparvus
orthologues can be found in Arcà et al. (12). The sequences were aligned with Clustal Omega (43).
A. gambiae cE5–thrombin interaction
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in line with the value previously reported (9, 10) and with that
obtained from the thrombin amidolytic activity inhibition
assays in this study (Table 2).
We also used NMR titration experiments and analysis of 2D
1H,15N HSQC spectra (23) to study protein-protein interac-
tions. HSQC spectra of 15N-labeled cE5 were recorded in
the absence and presence of increasing amounts of unlabeled
thrombin. At cE5/thrombin ratios 1/5, numerous spectral
changes could be observed, pointing to interactions taking
place between the two proteins (supplemental Fig. S3). How-
ever, it was not possible to reach saturating conditions, which
would have allowed gaining more detailed structural informa-
tion. This is most likely due to the relatively large size of the
complex, which caused severe line broadening and loss of sen-
sitivity in the NMR spectra (supplemental Fig. S3). In addition,
2D 1H,1H NMR spectra collected for the P2 peptide showed a
similar lack of relevant chemical shift dispersion and the
absence of a consistent number of nuclear Overhauser effect
(NOE) contacts, confirming a disordered state for the P2 pep-
tide in aqueous solution (supplemental Fig. S4, right panel).
Moreover, no significant change in either chemical shift and/or
NOE intensity could be observed when comparing 2D 1H,1H
NOESY (Nuclear Overhauser Enhancement Spectroscopy)
experiments with the P2 peptide (470 M) in the absence and
the presence of a substoichiometric amount of thrombin (25
M) (supplemental Fig. S4). These observations suggest that
under our experimental conditions, the peptide “dynamically”
binds to thrombin by preserving disorder and flexibility.
Thrombin inhibition assays
The inhibitory effect of cE5 and of peptides P1, P2, P3, and P5
on the in vitro amidolytic activity of thrombin was measured
after the hydrolysis of a fluorogenic substrate. A thrombin inhi-
bition of 80% was found for cE5, in line with previous mea-
surements using a chromogenic substrate (9). The P2 peptide
still retained inhibitory properties even though it was signifi-
cantly less effective than cE5 (39% inhibition), whereas nei-
ther P1 nor P3 affected thrombin activity (Fig. 6). The inhibi-
tory effect of P5 was not significantly different from those
observed using P2 alone or any combination including either P2
or P5.
Overall, thrombin inhibition results fit quite well with ITC
data, confirming that the region corresponding to the P2 pep-
tide (cE5(Asp-31–Arg-62)) is themain segment responsible for
both binding to thrombin and for the inhibitory activity. The P1
peptide (cE5(Ala-1–Ser-30)) did not bind thrombin and did not
affect its activity, and these results are fully consistent with pre-
vious observations on A. albimanus anophelin (10). Moreover,
our results seem to rule out any direct functional role of the
serine-rich C-terminal region in thrombin inhibition. In fact,
the P3 peptide alone did not bind to or inhibit thrombin, and
the P5 peptide, which encompasses both P2 and P3, was not a
better inhibitor or a more efficient binder than P2.
Overall structure of the A. gambiae cE5–human-thrombin
complex
The recombinant P5 fragment (cE5(Asp-310–Glu-82)) of A.
gambiae cE5 was crystallized in complex with human
-thrombin, and its structure was determined at 1.45 Å resolu-
tion (supplemental Table 1 and Fig. 7). There are three copies
(A, B, and C) of the complex in the asymmetric unit: complex A
comprising thrombin residues T(Ser-1E) to T(Arg-15) and
T(Ile-16) to T(Gly-246) and inhibitor residues cE5(Glu-35) to
cE5(Asn-63) (the chymotrypsinogen-based numbering will be
used for thrombin); complex B encompasses thrombin residues
T(Thr-1H) toT(Arg-15) andT(Ile-16) toT(Gly-246) and inhib-
itor residues cE5(Glu-36) to cE5(Leu-42) and cE5(Ala-46) to
cE5(Arg-62); finally, in complex C thrombin residues T(Gly-
1D) to T(Ile-14K), T(Ile-16) to T(Gln-244), and inhibitor resi-
dues cE5(Arg-52) to cE5(Leu-61) could bemodeled. In all com-
plexes, thrombin’s 149 insertion loop was disordered (from
T(Trp-148) to T(Lys-149E), T(Trp-148) to T(Gly-149D), and
T(Thr-147) toT(Gly-149D), for complexesA toC, respectively)
and could not be modeled. Although the three complexes are
structurally very similar (rootmean square deviations of 0.44Å,
0.82 Å, and 0.93 Å for the superposition of the proteinase moi-
eties of complexes A-B, A-C, and B-C, respectively), complex C
displays an unusual flexibility of segments of the heavy chain
of thrombin, encompassing residues T(Gln-38)–T(Lys-70),
T(Arg-101)–T(Glu-127), T(Met-210)–T(Cys-220), and T(Phe-
227)–T(Gln-244). Therefore, only complex A will be described
herewith (Fig. 7). No significant density was present for the
N-terminal tetrapeptide cE5(Asp-31) to cE5(Glu-34) or for the
C-terminal 21 amino acids (cE5(Ser-64) to cE5(Glu-82) of
the P5 fragment, and these segments were, therefore, excluded
from the model. Superposition of the structures of free throm-
bin (PDB entry 3U69; Ref. 22) and the proteinase moiety of the
A complex revealed that only minor rearrangements occur in
the proteinase uponA. gambiae cE5 binding (rootmean square
deviation of 0.36 Å for 277 aligned C atoms).
Unsurprisingly, A. gambiae cE5 displays the same unique
mode of thrombin inhibition observed for A. albimanus
anophelin (10), further confirming it as a general mechanism
for this class of inhibitors (MEROPS family I77; Ref. 24; Fig. 7B).
In agreement with the results of CD (Fig. 2) andNMRmeasure-
ments (Fig. 3), the inhibitor adopts a mostly extended confor-
mation, running in a reverse orientation to substrates on the
surface of thrombin and interacting with both the exosite I and
the active-site region of the proteinase (Fig. 7, A, C, and D).
Further supporting the observed binding mode, both full-
length A. gambiae cE5 and its truncated P5 fragment display 3
orders ofmagnitude larger inhibition constants toward the exo-
site I-disrupted -thrombin than toward-thrombin (Table 2).
Table 1
Binding properties of cE5, anophelin, and cE5-derived peptides to
thrombin as determined by ITC studies
ND, not detected.
Ligand Kd H n
cal/mol
cE5 1 0.2 nM 9,848 60 1
cE5a 0.3 nM 8,272 1
P1 (cE5(1–30)) ND ND ND
P2 (cE5(31–62)) 12 1 nM 9,663 34 1
P3 (cE5(63–82)) ND ND ND
P5 (cE5(31–82)) 25 1 nM 4,887 75 1
Anophelin 2 0.2 nM 14,120 90 1
a From displacement titration experiments.
A. gambiae cE5–thrombin interaction
12636 J. Biol. Chem. (2017) 292(30) 12632–12642
 at U
N
IV
ERSITÀ STUDI LA SAPIENZA on March 28, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Bidentate binding of cE5 to thrombin
Similar to the A. albimanus anophelin-thrombin complex
(10), the cE5 fragment spanning residues cE5(Glu-35) to
cE5(Asp-47) blocks the exosite I of the proteinase (Figs. 4 and
7C). However, despite the overall resemblance, the first half of
this cE5 segment runs closer to the proteinase surface, with its
main-chain atoms deviating significantly from the path of the
equivalent region of A. albimanus anophelin (Fig. 7B). The
inhibitor’s tripeptide cE5(Glu-35)–cE5(Glu-36)–cE5(Phe-37)
Table 2
Inhibition of human - and -thrombin by A. gambiae cE5
The affinity for thrombin of the P5 fragment is comparable with that of full-length
cE5. Disruption of thrombin’s exosite I decreases the inhibition potency of cE5 (and
P5) by 3 orders of magnitude. Ki values  S.E. given are representative of two
independent experiments.
Inhibitor -Thrombin -Thrombin
pM nM
cE5 5.50 1.26 3.79 0.16
P5 fragment 20.80 0.99 10.99 0.69
Figure 5. ITC analysis of thrombin binding to A. gambiae cE5, A. albimanus anophelin, and cE5-derived peptides. Isothermal titration calorimetry of
thrombin interaction with A. gambiae cE5 (A), A. albimanus anophelin (B), P1 (C), P2 (D), P3 (E), and P5 (F) is shown. The top and bottom panels report raw and
integrated data, respectively.
A. gambiae cE5–thrombin interaction
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establishes water-mediated main chain-main chain contacts
with thrombin’s T(Ile-82)–T(Ser-83)–T(Met-84) tripeptide.
This region is also stabilized by an intramolecular hydrogen
bond between the carbonyl oxygen of cE5(Asp-38) and the
amide nitrogen of cE5(Leu-41), further reinforced by two inter-
actions with the side chain of T(Gln-38), involving the main
chain nitrogen of cE5(Glu-43) and the carbonyl oxygen of
cE5(Leu-41). This conformation results in the placement of the
side chain of cE5(Phe-37) snuggly inside the hydrophobic
depression bordered by the side chains of T(Leu-65), T(Ile-82),
and T(Met-84), to which it establishes van der Waals interac-
tions. Additionally, the aromatic ring of cE5(Phe-37) also con-
tacts the side chain of the well-conserved cE5(Leu-42), in the
same position of the homologous A(Leu-41) of A. albimanus
anophelin, and in turn contacting T(Phe-34) and T(Tyr-76).
The side chains of cE5(Pro-39) and cE5(Leu-41) pack on top of
that cE5(Phe-37), completing this strong hydrophobic cluster.
Furthermore, toward the active site cleft of thrombin,
cE5(Asp-47) forms a salt bridge with T(Arg-73). Notably, the
replacement ofA. albimanus anophelinA(Phe-45) by themuch
shorter cE5(Ala-48) impairs the highly conserved stacking
interaction with T(Phe-34) observed in numerous thrombin
ligands, fromprotease-activated receptor 1 (PAR1) (25) to hiru-
din (26) and from boophilin (27) to anophelin (10). Instead, two
polar interactions are observed between the carbonyl oxygen of
cE5(Ala-48) and the side chains of T(Arg-73) and T(Gln-151).
From cE5(Pro-49) all the way to cE5(Arg-56), the interactions
established between thrombin and the homologous A(Thr-47–
Arg-53) segment of A. albimanus anophelin are strictly con-
served (10), in agreement with the remarkable amino acid
sequence conservation observed in all members of the family
(Fig. 4). Therefore, cE5(Arg-53) interacts with the catalytic
T(His-57) and T(Ser-195), whereas cE5(Arg-56) occupies the
S1 specificity pocket of the proteinase (Fig. 7D). The down-
streamcE5(Asn-57) interactswith the side chain ofT(Glu-192),
resembling the contact established by A. albimanus anophelin
A(Arg-54) (10), but the main chain of the remaining ordered
cE5(Pro-58)–cE5(Leu-61) tetrapeptide deviates considerably
from the homologous segment of anophelin (Fig. 7B). Despite
that, the position of the side chain of cE5(Phe-60) closely
resembles that ofA. albimanus anophelin A(Leu-55), therefore
occupying the aryl binding site of thrombin.
Discussion
Overall, the cE5 central region represented by the P2 peptide
appeared as the main responsible for both thrombin binding
and inhibition. The fact that only the cE5(Glu-35–Asn-63) seg-
ment of peptide P5 could be modeled in the crystal structure
and no significant electron density was detectable for the ser-
ine-rich C-terminal portion reinforces this main role of the
region corresponding to P2. Moreover, the C-terminal region
was not constrained by crystal packing, explaining its observed
disorder (supplemental Fig. S5). The binding of cE5 to throm-
bin was to a large extent similar to that previously described for
A. albimanus anophelin. Nonetheless, the cE5 N-terminal and
C-terminal regions still appear to play some role in both bind-
ing and inhibition. Indeed, when these two disordered seg-
ments were missing, we observed a decrease in binding affinity
(1 nM for cE5 versus 12 nM for P2) as well as in thrombin
inhibition (80% for cE5 versus 39% for P2). Thesemore efficient
binding and inhibitory properties of the full-length protein are
in agreement with the flanking model, already proposed for
interactions involving intrinsically disordered proteins (28, 29).
Unexpectedly, ITC studies indicated a negative contribution of
the C-terminal region encompassed by P3 (higherKd and lower
H values for P5 than for either P2 or the entire cE5 protein).
This conflicts with the conservation of the C-terminal serine-
rich extension among Old World anophelines, suggesting a
potential functional role for this region. However, specific
experimental conditions and/or the in vitro nature of our study
should be taken into account. The situation may be different in
vivo, where the regions encompassed by peptides P1 and P3
may provide interaction sites for other binding partners (e.g. the
RGD tripeptidemay be involved in binding to integrins) and/or
undergo post-translational modifications (as suggested from
the different mobility between recombinant and native cE5
protein in SDS-PAGE) (9). In conclusion, through structural,
functional, and binding studies we shed additional light on the
unique mechanism of thrombin binding and inhibition by this
family of salivary anticoagulants from anopheline mosquitoes.
It is anticipated here that future proteomic and structural stud-
ies on salivary proteins of hematophagous animals are expected
to provide insights into novel antihemostatic molecules and
novel mechanisms of disrupting blood clotting that may be of
great help in the design of novel antithrombotics. This appears
especially true considering (i) the fast evolutionary rate of sali-
vary proteins (11, 12), (ii) the convergent evolutionary nature of
hematophagy, and (iii) the fact that so far we acquired some
knowledge on the salivary repertoires of just a few of the
14,000 arthropod species estimated to feed on blood (30).
Experimental procedures
cE5 protein and peptides
Recombinant cE5 and 15N-labeled cE5 proteins were ex-
pressed and purified as described (9). The ORF encoding P5
(cE5(Asp-310–Glu-82)) was chemically synthesized (Life Tech-
nologies) and cloned into pETM11 (Novagen). Expression was
Figure 6. Thrombin inhibition assays. Residual thrombin activity in the
absence and the presence of A. gambiae cE5, or of the different peptides as
indicated, was measured after the hydrolysis of the fluorogenic substrate
Boc-Val-Pro-Arg-7-amido-4-methylcoumarin hydrochloride. Dots represent
data from three independent experiments, each in triplicate. Thick lines show
the mean values, and bars indicate S.D.
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performed as above. Protein integrity and purity was confirmed
by mass spectrometry (Agilent Q-TOF LC/MS). Peptides P1
(cE5(Ala-1–Ser-30), APQYARGDVPTYDEEDFDEESLK-
PHSSSSS), P2 (cE5(Asp-31–Arg-62), DDGEEEFDPSLLEEH-
ADAPTARDPGRNPEFLR), and P3 (cE5(Asn-63–Glu-82),
NSNTDEQASAPAASSSESDE) were purchased from INBIOS
S.r.l. (Naples, Italy). The A. albimanus anophelin was synthe-
sized at the Peptide Synthesis Laboratory, Research Technolo-
gies Branch, NIAID, National Institutes of Health (Rockville,
MD) by Dr. Jan Lukszo.
Circular dichroism analyses
CD spectra were recorded at 20 °C in the far UV (190–260
nm) on a Jasco J-710 spectropolarimeter (31). Each spectrum
was obtained averaging three scans, subtracting contributions
from corresponding blanks and converting the signal to mean
residue ellipticity in units of degree 	 cm2 	 dmol1. Spectra
were recorded using 10 M cE5 in 10 mM phosphate buffer at
pH 7.5 in the absence and in the presence of increasing concen-
trations (up to 60% (v/v)) of 2,2,2-trifluoroethanol (TFE, 99.5%
isotopic purity, Sigma). Prediction analysis of secondary struc-
ture content was performed with CDPro (31, 32).
Isothermal titration calorimetry
ITC studies were performed at 22 °C with an ITC200 calo-
rimeter (MicroCal/GE Healthcare). Anophelin and cE5 (100
M) or the peptides P1, P2, P3, and P5 (150 M) were titrated
into a solution of human -thrombin (20 M; Hematologic
Figure7. TheA. gambiae cE5anticoagulantblocksboth theactive site and theexosite I regionsofhuman-thrombin.A, the acidic cE5(Glu-35–Asp-47)
segmentof cE5 (stickmodelwithnitrogenatoms inblue, oxygen in red, andcarbon ingreen) binds to theexosite I of thrombin (solid surface representationwith
positive surfaceelectrostatic potential inblueandnegative surfaceelectrostatic potential in red),whereas thedownstreamsegment, up to cE5(Arg-62), threads
along the active site cleft of the proteinase, blocking the active site and the non-primed specificity subsites. The 2Fo Fc electron densitymap (1.0- contour)
for cE5 is representedasablackmesh.B, comparisonbetween theA. gambiae cE5P5 fragment (green) andA. albimanusanophelin (PDBentry4E05; Ref. 10;blue)
shown in schematic representation. Thrombin, shown as a solid white surface, is in the same orientation as in panel A. C, close-up view of the interactions
established between the N-terminal segment cE5(Glu-35–Glu-43) of cE5 (colored as in panel A) and the exosite I of thrombin (gray schematic with selected
residues as sticks color-coded as cE5, except for carbon atoms, colored tan). Water molecules and hydrogen bonds are represented as red spheres and dotted
black lines, respectively. D, close-up view of the interaction between the strictly conserved cE5(Arg-53–Arg-56) tetrapeptide and the active-site region of
thrombin (colors as in panel C). The figure was prepared with PyMOL (Schro¨dinger).
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Technologies Inc., HCT-0020). Before all titration experiments
proteins and peptides were dialyzed against 20 mM HEPES, pH
7.5, 50 mM NaCl. All data were analyzed and fitted using
the Microcal Origin version 7.0 software package. Binding
enthalpy, dissociation constants, and stoichiometrywere deter-
mined by fitting the data using a one-set-of-site-bindingmodel.
ITC runs were repeated twice to evaluate the reproducibility of
the results.
Nuclearmagnetic resonance spectroscopy
NMRspectrawere recorded at 298Kon aVarianUnity Inova
600 MHz spectrometer provided with a cold probe. 2D 1H,15N
HSQC spectra of 15N-labeled cE5were acquired by implement-
ing the following set of experimental conditions: 50mM sodium
phosphate buffer, pH 7.8; 550-l sample total volume; H2O/
D2O (98% deuterium, Armar Scientific, Switzerland) 90/10,
0.1%(w/v)NaN3; 5–40Mprotein concentration range. Similar
experiments were conducted in phosphate buffer containing
increasing amounts (10%, 30, and 60% (v/v)) of TFE. Water
suppression was achieved by Excitation Sculpting (33). NMR
spectra were processed with Varian software (Vnmrj version
1.1D) (34) and analyzed with the software NEASY that is
included in the Cara program (http://cara.nmr.ch/doku.php)3
(35). To monitor binding to thrombin, 2D 1H,15N HSQC spec-
tra of 15N-labeled cE5 (10 M) were recorded for the protein in
the free form and after addition of increasing amounts of unla-
beled thrombin (cE5/thrombin molar ratios: 1/1.4, 1/2.7, 1/4.2,
1/7). Analysis of titration experiments and overlays of 2D
spectra were performed with Sparky (36). In addition, 1H,1H
NOESY 300 (37) and TOCSY 70 (total correlation spectros-
copy) (38) experiments were recorded for the P2 peptide (470
M in 50 mM sodium phosphate pH 7.8) in its unbound form
and complexed to thrombin (25 M).
Thrombin inhibition assays
Inhibition of human -thrombin by cE5 and peptides P1, P2,
P3, or P5 was evaluated after the hydrolysis of the fluorogenic
substrate Boc-Val-Pro-Arg-7-amido-4-methylcoumarin hydro-
chloride (Boc, t-butoxycarbonyl; Sigma, B9385). Reactions
were carried out in a 100-l total volume in reaction buffer (50
mM Tris-HCl, pH 8.0, 50 mM NaCl2, 20 mM CaCl2, 0.01% (v/v)
Triton X-100). Human -thrombin (0.5 nM; Sigma, T7009) was
preincubated for 10 min at 37 °C with 100 nM recombinant cE5
or cE5-derived peptides. Reactions were initiated by the addi-
tion of substrate (250 M) and hydrolysis followed at 37 °C for
60 min at 460 nm (excitation  360 nm) on a Synergy HT
microplate reader (BioTek). Data represent three independent
experiments, each one in triplicate. Graphics and statistical
analysis were performed using GraphPad Prism 6.0 (GraphPad
Software, Inc. La Jolla, CA).
Thrombin amidolytic activity assay
The amidolytic activity of human-thrombin or -thrombin
(Hematologic Technologies) was followed using Tos-Gly-Pro-
Arg-p-nitroanilide (Chromozym TH; Roche Applied Science)
as the chromogenic substrate. Inhibition assays were per-
formed in 50 mM Tris, pH 8.0, 50 mM NaCl, 1 mg/ml bovine
serum albumin with 0.2 nM human -thrombin or -thrombin,
100 M substrate, and varying concentrations of inhibitor
(0–80 nM for -thrombin or 0–200 nM for -thrombin). Inhi-
bition constants (Ki) were determined according to a tight-
binding inhibitor model using theMorrison equation (39) with
GraphPad Prism 6.0. All reactions were initiated by the addi-
tion of thrombin and were carried out at least in duplicate at
37 °C in 96-well microtiter plates. Reaction progress was mon-
itored at 405 nm for 30 min on a Synergy2 multimode micro-
plate reader (BioTek).
Platelet assays
Inhibition of collagen-mediated platelet aggregation was
evaluated using human platelet-rich plasma obtained from
donors at the National Institutes of Health blood bank and
diluted to a density of 2	 105 platelets/l in Tyrode-BSA (40)
(final volume 300 l). cE5, P1, or an equal volume of Tyrode
buffer was added to each sample, which was then placed in an
aggregometer (40) and stirred at 1200 rpm at 37 °C for 1 min
before the addition of collagen (type-1 fibrils, Chrono-log) to a
concentration of 1.6 g/ml.
Crystallization of A. gambiae cE5 in complex with human
-thrombin
Human -thrombin (Hematologic Technologies) was mixed
in 20 mM HEPES, pH 7.5, 125 mM NaCl with a 4-fold molar
excess of P5 peptide (cE5(Asp-310–Glu-82)) and incubated on
ice for 1 h. The resulting complex was concentrated by ultrafil-
tration using a 2-kDa cutoff centrifugal device (Sartorius).
An initial crystallization screen at 20 °C on sitting drop
geometry was performed at the High Throughput Crystalli-
zation Laboratory of the European Molecular Biology Labo-
ratory (Grenoble, France). Preliminary crystallization condi-
tions were systematically optimized in-house until single
monoclinic crystals belonging to space group C2were obtained
after 4–6 days at 20 °C using the vapor diffusion sitting-drop
method from drops consisting of equal volumes (1 l) of pro-
tein complex (at 6.4 mg/ml) and precipitant solution (0.1 M
PCTP, pH 5.0, 25% (w/v) PEG 1500) equilibrated against a
300-l reservoir.
Data collection and processing
Crystals were cryoprotected by brief immersion in 0.1 M
PCTP, pH 5.0, 20% (w/v) PEG1500, 20% (v/v) ethylene glycol or
0.1 M PCTP, pH 5.0, 35% (w/v) PEG1500 and flash-cooled in
liquid nitrogen. Diffraction data were collected from two iso-
morphous crystals (2100 and 2400 images in 0.05° oscillation
steps and 0.037-s exposure) on aPilatus 6M-Fdetector (Dectris)
using a wavelength of 0.973 Å at beam line ID30B of the Euro-
pean Synchrotron Radiation Facility (Grenoble, France). Data
were integrated with XDS (41), scaled with XSCALE (41), and
reduced with utilities from the CCP4 program suite (42). Data
collection statistics are summarized in supplemental Table 1.
The raw experimental datasets for the three-dimensional struc-
ture reported in this manuscript (PDB 5NHU) are available in
the SBGrid Data Bank (https://data.sbgrid.org/data/)3 (45)
(Ripoll-Rozada, J., and Pereira, P. J. B. (2017) X-ray diffraction
data for human thrombin-A. gambiae cE5 complex–datasets 1
and 2. Structural Biology Data Grid, V1, http://dx.doi.org/
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10.15785/SBGRID/430 and http://dx.doi.org/10.15785/
SBGRID/431).
Structure determination and refinement
The structure of the complex was solved by molecular
replacement with PHASER (46) using the coordinates of free
wild-type human -thrombin (PDB entry 3U69; Ref. 22) as the
searchmodel. Alternating cycles ofmodel buildingwith COOT
(47) and refinement with PHENIX (48) were performed until
model completion (refinement statistics are summarized in
supplemental Table 1). All crystallographic software was sup-
ported by SBGrid (49). Refined coordinates and structure fac-
tors were deposited at the PDB with accession number 5NHU.
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